{
    "clinical_study": {
        "@rank": "45066", 
        "acronym": "EAPMH", 
        "arm_group": [
            {
                "arm_group_label": "the affected  meridian acupuncture group", 
                "arm_group_type": "Experimental", 
                "description": "We select the acupoints from the affected meridians.Patients in this group are divided into two subgroups according meridian syndrome differentiation(jue-yin style,yang-ming style).Patients pertaining to Jue-yin-style are treated with taichong (LR3), renying(ST9), taixi(KI3), neiguan(PC6) .Patients pertaining to Yang-ming-style: taichong(LR3), renying(ST9), zusanli(ST36),  quchi(LI11)."
            }, 
            {
                "arm_group_label": "the non-affected  meridian acupuncture", 
                "arm_group_type": "Active Comparator", 
                "description": "We select the acupoints from the non-affected meridians.Patients assigned into the non-affected meridian acupuncture group will be treated with Fengchi (GB20), waiguan(SJ5), yinlingquan(SP9), xuehai (SP10) ."
            }, 
            {
                "arm_group_label": "Invasive sham acupuncture", 
                "arm_group_type": "Sham Comparator", 
                "description": "we use sham acupoints:\nThe edge of the tibia (1-2cm lateral and horizontal to the zusanli (ST36))\nHalf way between the tip of the elbow and the axilla\nOn the ulnar side of the arm, half way between the epicondylus medialis of the humerus and the ulnar side of the wrist.\n2cm superior to fu tu(LI18)"
            }, 
            {
                "arm_group_label": "Waiting-list", 
                "arm_group_type": "No Intervention", 
                "description": "Participants who will be randomized into the WL group will not receive any acupuncture treatment throughout 13-week observation period. At the end of trial, if the participant would like to be treated with acupuncture, it will be provided three times weekly for 6 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a large scale, open-label, multicenter, randomized controlled clinical trial with\n      four parallel arms. This trial aims to evaluate the effectiveness of affected meridian\n      acupuncture for patients with mild hypertension,with respect to decreasing  their blood\n      pressure, safety of acupuncture ,and improving their quality of life as well."
        }, 
        "brief_title": "Effect of Acupuncture on Patients With Mild Hypertension", 
        "completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Essential Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "Investigators plan to recruit 428 hypertensive patients. Eligible patients will be\n      randomized to four different groups.\u2170. the affected meridian acupuncture group (AMA, n=107)\n      will be treated with acupoints on affected meridians.\u2171.the non-affected meridian acupuncture\n      group (NMA, n=107) will be treated with acupoints on non-affected meridians.\u2172.invasive sham\n      acupuncture group(ISA, n=107)will be provided with sham acupoints treatment.\u2173.waiting-list\n      group(WL, n=107)will not be given any intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\uff1a\n\n          1. Patients whose age between 40 and 75 years old, male and female;\n\n          2. Patients who meet the diagnostic criteria of mild hypertension  according to JNC-7\n             and China's prevention and cure guide of hypertension. mild  hypertension (WHO/ISH\n             criteria stage I) Systolic blood pressure 159\u2265(SBP) \u2265140 and/or diastolic blood\n             pressure 99\u2265(DBP) \u226590 .\n\n          3. Patients who are initially diagnosed as mild hypertension or have been diagnosed as\n             mild hypertension before but have not taken any antihypertensive drugs.\n\n          4. Patients who are diagnosed as yue-yin style (yin-deficiency accompany with\n             hyperactivity of yang) or yang-ming style (obstruction of phlegm and dampness)\n             according to meridian syndrome differentiation\n\n          5. Patients who have a good understanding of our study. and willing to comply with our\n             study protocol.\n\n          6. Informed consent form must be signed by patient or lineal relative.\n\n          7. All the tips are matched will be included.\n\n        Exclusion Criteria:\n\n          1. Patients who have been diagnosed as secondary hypertension or malignant\n             hypertension(e.g. Cushing's syndrome, coarctation of the aorta\uff0cphaeochromocytoma,\n             renal parenchymal disease\uff0cprimary aldosteronism\uff0c renovascular hypertension,\n             obstructive sleep apnoea\uff0cdrug induced hypertension et al )\n\n          2. Patients who accompany with other severe medical conditions (e.g. endocrine\n             disorders, cardiovascular disease. Digestive disease. hepatic dysfunction\uff0ccerebral\n             vascular disease. renal disease. haematologic disease et al). Who may be not safe to\n             join our study.\n\n          3. Patients with a chronic disease which might not suitable for our study. e.g: epilepsy\n             ,severe depression or anxiety (SAS\u226570,SDS\u226570) ,psychosis, allergic constitution,\n             accompany with any infection.\n\n          4. Pregnant women or women in lactation or women of child bearing potential plan to\n             conceive in the recent six months.\n\n          5. Patients who currently participate in another clinical trial.\n\n          6. Patients who Had been treated with acupuncture during the previous three months\n\n          7. If one of the tips mentioned above is matched will be excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "428", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01701726", 
            "org_study_id": "2012CB518501-1"
        }, 
        "intervention": {
            "arm_group_label": [
                "the affected  meridian acupuncture group", 
                "the non-affected  meridian acupuncture", 
                "Invasive sham acupuncture"
            ], 
            "description": "In each session, acupuncture are applied bilaterally. Except the acupoints around the neck(ST9.GB20.non-acupoints 4) ,6 auxiliary needles will be punctured at 2mm lateral to each acupoints or non-acupoints.as to auxiliary needle we will not do any manipulation. We use transcutaneous electric acupoints stimulation  to stimulate the acupoints and non-acupoints.", 
            "intervention_name": "acupuncture", 
            "intervention_type": "Other", 
            "other_name": [
                "electroacupuncture", 
                "acupuncture and moxibustion"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Essential Hypertension", 
            "Acupuncture", 
            "Specificity", 
            "Acupoints effect", 
            "randomized controlled trials"
        ], 
        "lastchanged_date": "May 10, 2013", 
        "location": {
            "contact": {
                "email": "acuresearch@126.com", 
                "last_name": "fan-rong Liang, MD", 
                "phone": "86-13438151411"
            }, 
            "facility": {
                "address": {
                    "city": "Chengdu", 
                    "country": "China", 
                    "state": "Sichuan", 
                    "zip": "610075"
                }, 
                "name": "Chengdu University of Traditional Chinese Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of Acupuncture on Patients With Mild Hypertension: an Open-label Multicenter Randomized Controlled Trial", 
        "overall_contact": {
            "email": "acuresearch@126.com", 
            "last_name": "fan-rong Liang, MD", 
            "phone": "86-13438151411"
        }, 
        "overall_official": {
            "affiliation": "Chengdu University of Tranditional Chinese Medicine", 
            "last_name": "fan-rong Liang, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Science and Technology", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome is the average systolic and average diastolic blood pressure measured at 6 weeks after randomization by 24-hour ambulatory blood pressure monitoring.", 
            "measure": "Average systolic and average diastolic blood pressure by 24-hour ambulatory blood pressure monitoring", 
            "safety_issue": "No", 
            "time_frame": "6weeks after randomization."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01701726"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The daytime is defined as 8AM-10PM.Nighttime is defined as 10PM -8AM.", 
                "measure": "Average systolic and average diastolic blood pressure during the daytime and nighttime.", 
                "safety_issue": "No", 
                "time_frame": "0 day, 6weeks, 9weeks, 12weeks after randomization."
            }, 
            {
                "description": "SF-36 (Medical Outcomes Study 36-Item Short Form)questionnaire Chinese version. The scale contains eight dimensions (physical function, role physical, bodily pain, general health, vitality, social function, role emotional, mental health) and two summary components (physical and mental ),scale 0-100.lower scores indicate poorer quality of life.", 
                "measure": "changes in patients health-related quality of life", 
                "safety_issue": "No", 
                "time_frame": "0 day and 6 weeks after randomization."
            }, 
            {
                "description": "This will be measured by a self-administered questionnaire with 7 items.", 
                "measure": "expectation of the treatment", 
                "safety_issue": "No", 
                "time_frame": "0 day after randomization."
            }, 
            {
                "description": "Adverse events are defined as any unexpected or discomfort signs, symptoms or diseases, regardless of the intervention. If any adverse events happen during the entire observation period, all the details should be documented in the case report form. These adverse events include bleeding, hematoma, fainting, serious pain, and local infection.", 
                "measure": "Adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "0 day, 6weeks, 9weeks, 12weeks after randomization"
            }
        ], 
        "source": "Chengdu University of Traditional Chinese Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "Hunan University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Chengdu University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}